Tandem Diabetes Care Stock Forecast
Stronger technical forecast for Tandem Diabetes Care stock price after Thursday trading.
(Updated on Apr 25, 2024)
The Tandem Diabetes Care stock price gained 1.25% on the last trading day (Thursday, 25th Apr 2024), rising from $35.12 to $35.56. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.90% from a day low at $34.91 to a day high of $36.27. The price has been going up and down for this period, and there has been a 4.99% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 577 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $55.75 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.65% during the next 3 months and, with a 90% probability hold a price between $47.13 and $59.47 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TNDM Signals & Forecast
The Tandem Diabetes Care stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $32.93 and $32.29. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 16.86%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Tandem Diabetes Care stock
On the downside, the stock finds support just below today's level from accumulated volume at $28.86 and $27.11. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tandem Diabetes Care finds support just below today's level at $28.86. If this is broken, then the next support from accumulated volume will be at $27.11 and $27.07.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.36 between high and low, or 3.90%. For the last week, the stock has had daily average volatility of 4.94%.
Our recommended stop-loss: $34.19 (-3.86%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)
Trading Expectations (TNDM) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Tandem Diabetes Care to open at $35.58, and during the day (based on 14 day Average True Range), to move between $33.75 and $37.37, which gives a possible trading interval of +/-$1.81 (+/-5.09%) up or down from last closing price. If Tandem Diabetes Care takes out the full calculated possible swing range there will be an estimated 10.18% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $28.86, some $6.70 (18.84%) from the current price of $35.56, our system finds the risk reward attractive.
Earnings coming up
Tandem Diabetes Care will release earnings AMC on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.80. We will update the financials statements for Tandem Diabetes Care, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.53% in the first trading day after earnings release.
Is Tandem Diabetes Care stock A Buy?
Tandem Diabetes Care holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score: 6.100 Strong Buy Candidate Upgraded
Predicted Opening Price for Tandem Diabetes Care of Friday, April 26, 2024
Fair opening price April 26, 2024 | Current price |
---|---|
$35.58 ( 0.0562%) | $35.56 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TNDM
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 36.94 | 3.88 % | |
R2 | 36.42 | 2.42 % | ||
R1 | 36.10 | 1.52 % | ||
Current price: | 35.56 | |||
Support | S1 | 35.06 | -1.40 % | |
S2 | 34.74 | -2.31 % | ||
S3 | 34.22 | -3.77 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0 | . | |
R2 | 0 | . | ||
R1 | 0 | . | ||
Current price | 35.56 | |||
Support | S1 | 28.86 | -18.84% | |
S2 | 27.11 | -23.78% | ||
S3 | 27.07 | -23.88% |
FAQ
Click here for our free guide on how to buy Tandem Diabetes Care Stock.